A clinical-stage biotechnology company developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system.
GenSight Biologics S.A.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”SIGHT.PA” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.gensight-biologics.com
Founded2012
Disease Focus
Development StageClinical
STOCK CODEEPA: SIGHT
Address74, rue du Faubourg Saint-Antoine 75012 ParisFrance
74, rue du Faubourg Saint-Antoine 75012
Paris
France
Contact Number+33 1 76 21 72 20
+33 1 76 21 72 20
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/gensight-biologics-sa” connections=”true” suffix=””]